Tune into our latest webinar which explores the diagnosis and day-to-day management strategies of giant cell arteritis (GCA). Expert in the field Qasim Akram, Stockport NHS Foundation Trust, UK, ...

The most dramatic symptoms of GCA (for example, visual loss) result directly from the inflammation of the large- and medium-sized cranial vessels. Other symptoms appear nonspecific and are related to ...

A common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant cell arteritis, according to findings from a team at the Perelman School of ...

5. Positive temporal artery biopsy Biopsy specimen with the artery showing vasculitis characterized by prominence of mononuclear cell infiltration or granulocyte inflammation, often with ...

Neutrophil-to-lymphocyte ratio as a clinical biomarker for immune checkpoint inhibitor response in advanced sarcoma. IMM2510, an anti-PD-L1/VEGF bispecific antibody fusion protein, in patients with ...

Please provide your email address to receive an email when new articles are posted on . At the Congress on Controversies in Ophthalmology, Lee and Susan Mollan, MBChB, FRCOphth, PhD, debated this ...

Findings showed 46.4% of patients treated with upadacitinib 15 mg achieved sustained remission compared with 29.0% of those who received placebo. The Food and Drug Administration (FDA) has approved ...

Patients presenting with isolated extracranial manifestations of giant cell arteritis represent a distinct phenotype that is associated with younger age at diagnosis and more frequent polymyalgia ...